title: Differential inhibition of nerve growth factor responses by purine analogues: correlation with inhibition of a nerve growth factor-activated protein kinase.
abstract: Purine analogues were used in this study to dissect specific steps in the mechanism of action of nerve growth factor (NGF). Protein kinase N (PKN) is an NGF-activated serine protein kinase that is active in the presence of Mn++. The activity of PKN was inhibited in vitro by purine analogues, the most effective of which was 6-thioguanine (apparent Ki = 6 microM). Several different criteria indicated that 6-thioguanine is not a general inhibitor of protein kinases and that it is relatively specific for PKN. For instance, it did not affect protein kinases A or C and was without effect on the overall level and pattern of protein phosphorylation by either intact or broken PC12 cells. Since purine analogues rapidly and effectively enter cells, they were also assessed for their actions on both transcription-dependent and -independent responses of PC12 cells to NGF. NGF-promoted neurite regeneration was reversibly suppressed by the analogues and at concentrations very similar to those that inhibit PKN. Comparable concentrations of the analogues also blocked NGF-stimulated induction of ornithine decarboxylase activity. In contrast to its inhibition of neurite regeneration and ornithine decarboxylase induction, 6-thioguanine did not suppress NGF-dependent induction of c-fos mRNA expression. Thus, purine analogues such as 6-thioguanine appear capable of differentially suppressing some, but not other actions of NGF. These findings suggest the presence of multiple pathways in the NGF mechanism and that these can be dissected with purine analogues. Moreover, these data are compatible with a role for protein kinase N in certain of these pathways.
authors.affiliation: Department of Pathology, College of Physicians and Surgeons of Columbia University, New York 10032.
authors.forename: C
authors.initials: C
authors.lastname: Volonté
authors.forename: A
authors.initials: A
authors.lastname: Rukenstein
authors.forename: D M
authors.initials: DM
authors.lastname: Loeb
authors.forename: L A
authors.initials: LA
authors.lastname: Greene
mesh_terms: D015075:2-Aminopurine / Q000494:pharmacology*; D000225:Adenine / Q000031:analogs & derivatives*; D000310:Adrenal Gland Neoplasms; D000818:Animals; D001369:Axons / Q000502:physiology; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D002460:Cell Line; D007700:Kinetics; D009414:Nerve Growth Factors / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009416:Nerve Regeneration / Q000187:drug effects; D009955:Ornithine Decarboxylase / Q000378:metabolism; D010673:Pheochromocytoma; D011493:Protein Kinase C; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000302:isolation & purification / Q000378:metabolism*; D013866:Thioguanine / Q000494:pharmacology*
chemical_list: D009414:Nerve Growth Factors; D047428:Protein Kinase Inhibitors; D015075:2-Aminopurine; D011494:Protein Kinases; C061570:protein kinase N; D011493:Protein Kinase C; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D009955:Ornithine Decarboxylase; D013866:Thioguanine; D000225:Adenine